Retinal vascular occlusion affects the eye, specifically the retina. The retina is the light-sensitive layer of tissue that lines the back of your eye. It’s covered with special cells called rods and ...

CRVO occurs when blood can no longer travel through the main blood vessel that brings blood to the back of the eye. This can cause swelling, and it may lead to vision loss. The retina is a layer of ...

We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving adults with acute, nonarteritic central retinal artery occlusion who had symptom onset within 4.5 hours ...

The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated evidence supporting its continued efficacy and safety over longer treatment ...

June 24, 2009 — On June 17, the US Food and Drug Administration (FDA) approved a dexamethasone 0.7-mg intravitreal implant (Ozurdex, Allergan, Inc) for the treatment of macular edema after branch ...

A population-based cohort study found that patients with retinal vein occlusion (RVO) 40 years and older had increased risk of cardiovascular disease CVD compared with patients who did not have RVO.

Former Pakistan Prime Minister, currently in jail, underwent a medical procedure for a threatening eye condition at a government hospital, an official said. According to officials, Khan was diagnosed ...

Please provide your email address to receive an email when new articles are posted on . A literature search identified 70 eyes with retinal vasculitis or vascular occlusion following brolucizumab for ...

Please provide your email address to receive an email when new articles are posted on . The European Commission approved Vabysmo for the treatment of visual impairment due to macular edema secondary ...

Retinal vascular occlusion (RVO) occurs when small veins in the back of the eye become blocked, and blood cannot flow through them. The condition can affect vision but does not cause total blindness.